| 1 |
35260366 | PET/Computed Tomography: Laryngeal and Hypopharyngeal Cancers. | 2022 Apr |
1 |
| 2 |
33165255 | Impact of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography on the initial staging and changing the management intent in head and neck squamous cell carcinoma. | 2021 Feb 1 |
1 |
| 3 |
33456531 | Accuracy of 18F-FDG PET/CT and CECT for primary staging and diagnosis of recurrent gastric cancer: A meta-analysis. | 2021 Feb |
1 |
| 4 |
33551083 | Esophageal Cancer: Tumor-Node-Metastasis Staging. | 2021 Mar |
1 |
| 5 |
33768290 | Added value of [18F]FDG PET/MRI over MDCT alone in the staging of recurrent gastric cancer. | 2021 Oct |
1 |
| 6 |
34102690 | Diagnosis and staging of hepatobiliary malignancies: Potential incremental value of (18)F-FDG-PET/MRI compared to MRI of the liver. | 2021 Oct |
1 |
| 7 |
34277098 | Differences between TNM classification and 2-[18F]FDG PET parameters of primary tumor in NSCLC patients. | 2021 |
1 |
| 8 |
34321915 | Influencing Factors and Prognostic Value of 18F-FDG PET/CT Metabolic and Volumetric Parameters in Non-Small Cell Lung Cancer. | 2021 |
1 |
| 9 |
30968855 | [Role of 18F-FDG PET/CT in comparison with CECT for whole-body assessment of patients with esophageal cancer.] | 2019 Mar |
2 |
| 10 |
25774234 | Correlation of Primary Tumor FDG Uptake with Clinicopathologic Prognostic Factors in Invasive Ductal Carcinoma of the Breast. | 2015 Mar |
1 |
| 11 |
26885142 | Pre-operative TNM staging of primary colorectal cancer by (18)F-FDG PET-CT or PET: a meta-analysis including 2283 patients. | 2015 |
1 |
| 12 |
16567772 | Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. | 2006 Apr 20 |
1 |
| 13 |
15856477 | Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. | 2005 Jun 1 |
1 |
| 14 |
14693872 | Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. | 2003 Dec 24 |
1 |
| 15 |
11831398 | The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers. | 2001 Dec |
1 |